QMS Medical Allied Services Ltd Q1 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 5 Aug 2026 | Healthcare Equipment & Supplies | Market Cap: ₹216 Cr
QMS Medical Allied Services aims for strong growth by leveraging its leadership in B2B pharma promotion and patient service programs. - Q-Devices wellness products expected to grow from Rs. QMS Medical Allied Services aims for robust growth with a focus on expanding services, especially in patient service programs and CAMS. - The services segment, including Saarathi, is targeted to grow by 50% year-on-year. - For FY '26, Q-Devices (B2C wellness products) is expected to achieve at least Rs.
From QMS Medical Allied Services Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹148
Market Cap
₹216 Cr
P/E Ratio
21.4
How does QMS Medical Allied Services Ltd rank in Healthcare Equipment & Supplies?
Compare QMS Medical Allied Services Ltd against every Healthcare Equipment & Supplies company this quarter on revenue, margins and earnings-call signals.
QMS Medical Allied Services Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹37 Cr, net profit ₹3 Cr.
Full financials →📊 Revenue & Sales Performance
- →QMS Medical Allied Services aims for strong growth by leveraging its leadership in B2B pharma promotion and patient service programs.
- →Q-Devices wellness products expected to grow from Rs. 10 crores in Q1 FY'26 to a conservative target of Rs. 25 crores in FY'26.
- →Services business (including Saarathi acquisition) targets 50% year-on-year growth, expecting to cross Rs. 60 crores revenue combining QMS and Saarathi.
- →The company plans to expand patient service programs and CAMS into new sectors like corporate healthcare and government programs.
- →QMS aims to increase market share in the emerging patient service program space, estimated globally at $70 billion.
- →Focus on enhancing distribution through non-traditional channels like CSC and e-Grameen for wellness products.
- →Pursuing inorganic growth opportunities in B2B and services sectors to accelerate revenue growth.
📈 Profitability & Margins
- →QMS Medical Allied Services aims for robust growth with a focus on expanding services, especially in patient service programs and CAMS.
- →The services segment, including Saarathi, is targeted to grow by 50% year-on-year.
- →For FY '26, Q-Devices (B2C wellness products) is expected to achieve at least Rs. 25 crores in revenue, up from Rs. 10 crores in Q1 alone.
- →The combined services revenue (QMS + Saarathi) is expected to cross Rs. 60 crores with higher margins, as services have roughly double the margins of products.
- →The company targets further inorganic growth opportunities in the pharma promotion sector.
- →Consistent improvement in EBITDA and profit after tax was shown in Q1 FY '26; management is confident in continuing this upward trend.
- →The company focuses on accountability, innovation, efficiency, and expanding its institutional client base, targeting higher earnings and stakeholder value creation.
🏗️ Capital Expenditure Plans
💰 Fundraising & Capital Structure
📋 Order Book & Pipeline
- →There is no specific mention of the current or expected order book or pending orders in the transcript.
- →However, it is noted that QMS's B2C wellness products (Q-Devices) achieved Rs. 10 crores revenue in Q1 FY'26, with a conservative full-year target of Rs. 25 crores, indicating ongoing and expected sales orders.
- →The company is enrolled as a healthcare vendor on the e-Grameen portal, which offers substantial potential to expand product distribution and generate new orders.
- →The patient service programs and CAMS business, including Saarathi acquisition, are growing with a target to grow services revenue by 50% annually.
- →Institutional client base includes over 130 clients including top 50 pharma companies across 5,000+ pin codes, implying steady service orders.
- →New projects like the Humrahi program contribute around 6%-7% of turnover, suggesting ongoing service engagement orders.
Key Metrics
Frequently Asked Questions
What were QMS Medical Allied Services Ltd Q1 FY26 results?
QMS Medical Allied Services aims for strong growth by leveraging its leadership in B2B pharma promotion and patient service programs. - Q-Devices wellness products expected to grow from Rs. QMS Medical Allied Services aims for robust growth with a focus on expanding services, especially in patient service programs and CAMS. - The services segment, including Saarathi, is targeted to grow by 50% year-on-year. - For FY '26, Q-Devices (B2C wellness products) is expected to achieve at least Rs.
What is QMS Medical Allied Services Ltd share price analysis?
QMS Medical Allied Services Ltd currently shows a neutral. The stock trades at a P/E of 21.4 with a market cap of ₹216 Cr. Investors should review the full earnings analysis for detailed insights.
Is QMS Medical Allied Services Ltd planning capital expenditure?
The transcript does not explicitly mention any current or future capex or capital investment plans.
Keep QMS Medical Allied Services Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.